Simultaneous determination of oxymatrine and its active metabolite matrine in dog plasma by liquid chromatography–mass spectrometry and its application to pharmacokinetic studies
2005; Elsevier BV; Volume: 817; Issue: 2 Linguagem: Inglês
10.1016/j.jchromb.2005.01.003
ISSN1873-376X
AutoresSujun Wang, Guangji Wang, Xiaotian Li, Jianguo Sun, Ren-ling Ma, Longsheng Sheng,
Tópico(s)Receptor Mechanisms and Signaling
ResumoA simple, rapid and reliable method was developed for the quantification of oxymatrine (OMT) and its metabolite matrine (MT) in beagle dog plasma using a liquid–liquid extraction procedure followed by liquid chromatography–electrospray ionization mass spectrometric (LC–ESI-MS) analysis. Extend-C18 column (2.1 mm i.d. × 50 mm, 5 μm) with a C18 guard column (2.1 mm i.d. × 12.5 mm) was used as the analytical column. Linear detection responses were obtained for OMT concentration ranging from 5 to 4000 ng/ml and for MT concentration ranging from 5 to 2000 ng/ml. The precision and accuracy data, based on intra- and inter-day variations over 5 days, were lower than 5%. The limit of quantitation for OMT and MT were 2 and 1 ng/ml, respectively, and their recoveries were greater than 90%. Pharmacokinetic data of OMT and its active metabolite MT obtained with this method following a single oral dose of 300 mg OMT capsules to six beagle dogs was also reported for the first time.
Referência(s)